...

KOTAI Biotechnologies, Inc

Visit website

About the employer

The repertoire of immune cell receptors has direct consequences for resistance to infection, autoimmune disease and cancer.

KOTAI’s platform technology can reveal the structure and function of immune cell receptors with unprecedented resolution from a routine blood sample.

Our vision is to provide technology that reveals the functional state of the immune system at the molecular level.

The only high-throughput structural modeling and analysis platform for immune cell sequences.

  • ACCURACY
    Our B and T cell receptor modeling technology is the most accurate available. Typical errors for backbone residues is less than 1 Angstrom.
  • SPEED
    The current version of Repertoire Builder produces 1,000 models per day on a single processor, and scales linearly with the number of processors.
  • SOPHISTICATION
    Using sequence and structural features from B or T cell receptor models, Repertoire Builder can group receptors according to their target epitopes, revealing the functional landscape of a donor and quantifying differences between donors.

Employer location

Discover similar employers

...
Wenzhou-Kean University Wenzhou, China 35 open positions
...
KIMEP University Almaty, Kazakhstan 12 open positions
...
University of Nizwa Nizwá, Oman 10 open positions
...
American University of Iraq - Baghdad Baghdad, Iraq 7 open positions
...
University of Nicosia Medical School Nicosia, Cyprus 4 open positions
More employers

This might interest you

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 min read
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 min read
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 min read
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 min read
More stories